Academic History
Geoffrey Shouse, DO, PhD, is a Hematologist-Oncologist and Researcher at City of Hope, Duarte, CA.
After completing a BS in Biology and a PhD in Cell, Molecular, and Developmental Biology at the University of California Riverside, Riverside, CA, Dr Shouse went on to do a PhD in Osteopathic Medicine at Western University of Health Sciences, Pomona, CA. He has done a Fellowship in Hematology and Medical Oncology at Loma Linda University Medical Center, Loma Linda, CA, and a Fellowship in Bone Marrow Transplantation at City of Hope, Duarte, CA.
Dr Shouse’s research aims to improve lymphoma treatment through innovative clinical trials focused on cellular therapies, molecular targeted therapies, and immunotherapy. He leads studies on CAR T-cell therapy and stem cell transplantation, while also addressing treatment toxicity in older adults. Additionally, Dr Shouse works to enhance access to care, particularly for underrepresented minorities in lymphoma clinical trials.
Speaking on novel treatment approaches for NHL, including CAR-T and bispecifics
Dr Shouse shares clinical trial data investigating novel treatment approaches for non-Hodgkin lymphoma (NHL). These include immunotherapy treatments such as CAR T-cells and bispecific antibodies.
